Knicks’ Achiuwa Strains Hamstring, Will Be Reassessed in 2-4 Weeks

Knicks forward/center Precious Achiuwa has strained his left hamstring and will be sidelined for at least the next two-to-four weeks, New York has announced (Twitter link). At that point, the 6’8″ big man will have the injury reevalauted.

It’s a big blow for New York’s frontcourt depth, compounding the health issues the team was already facing in that department to kick off its 2024/25 season. New York is already expecting to be without center Mitchell Robinson until at least January.

Losing Robinson and now Achiuwa means the Knicks will have to lean on deeper-bench options behind All-Star big man Karl-Anthony Towns, with Jericho Sims seemingly the likeliest player to benefit from a major minutes uptick. Seven-foot rookie center Ariel Hukporti, the No. 58 pick in this year’s draft, could conceivably even get a look. Forwards such as OG Anunoby could also see action at the five in smaller lineups.

As James L. Edwards of The Athletic notes (via Twitter), the Knicks’ bench will be exceedingly green to start the year. Only three of the team’s healthy reserves have prior NBA playing experience.

New York first acquired Achiuwa as part of its trade for Anunoby midway through 2023/24. He proved his mettle as a talented two-way presence in the paint for a 50-win Knicks squad. Across his 49 contests with the team (18 starts), Achiuwa posted solid averages of 7.6 PPG, 7.2 RPG, 1.1 APG, 1.1 BPG and 0.6 SPG.

The Memphis alum earned a one-year, $6MM deal to stick with New York as a free agent this summer.

New York’s starting unit of Towns, Anunoby, All-NBA point guard Jalen Brunson, three-and-D shooting guard Josh Hart, and newly acquired All-Defensive forward Mikal Bridges is shaping up to be one of the most fearsome in the entire league. With health-related challenges emerging early on, it remains to be seen how head coach Tom Thibodeau will balance a desire to lean heavily on his starters for early wins with the team’s bigger postseason aspirations.

View Comments (29)